JP2023025108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023025108A5 JP2023025108A5 JP2022188263A JP2022188263A JP2023025108A5 JP 2023025108 A5 JP2023025108 A5 JP 2023025108A5 JP 2022188263 A JP2022188263 A JP 2022188263A JP 2022188263 A JP2022188263 A JP 2022188263A JP 2023025108 A5 JP2023025108 A5 JP 2023025108A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- ile
- trp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 89
- 238000000034 method Methods 0.000 claims 50
- 150000001413 amino acids Chemical class 0.000 claims 24
- 229920001184 polypeptide Polymers 0.000 claims 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims 24
- 102000004196 processed proteins & peptides Human genes 0.000 claims 24
- 108091008874 T cell receptors Proteins 0.000 claims 11
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 11
- 210000005260 human cell Anatomy 0.000 claims 10
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 239000013604 expression vector Substances 0.000 claims 6
- 238000003259 recombinant expression Methods 0.000 claims 6
- 210000000265 leukocyte Anatomy 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims 1
- 108010037618 HLA-C*08 antigen Proteins 0.000 claims 1
- 101000986084 Homo sapiens HLA class I histocompatibility antigen, C alpha chain Proteins 0.000 claims 1
- 210000005104 human peripheral blood lymphocyte Anatomy 0.000 claims 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562218688P | 2015-09-15 | 2015-09-15 | |
| US62/218,688 | 2015-09-15 | ||
| PCT/US2016/050875 WO2017048593A1 (en) | 2015-09-15 | 2016-09-09 | T cell receptors recognizing hla-cw8 restricted mutated kras |
| JP2018513423A JP7185524B2 (ja) | 2015-09-15 | 2016-09-09 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513423A Division JP7185524B2 (ja) | 2015-09-15 | 2016-09-09 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023025108A JP2023025108A (ja) | 2023-02-21 |
| JP2023025108A5 true JP2023025108A5 (cg-RX-API-DMAC7.html) | 2023-04-25 |
| JP7461445B2 JP7461445B2 (ja) | 2024-04-03 |
Family
ID=56985686
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513423A Active JP7185524B2 (ja) | 2015-09-15 | 2016-09-09 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
| JP2022188263A Active JP7461445B2 (ja) | 2015-09-15 | 2022-11-25 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513423A Active JP7185524B2 (ja) | 2015-09-15 | 2016-09-09 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10556940B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3901169B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7185524B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20250117744A (cg-RX-API-DMAC7.html) |
| CN (2) | CN108350059B (cg-RX-API-DMAC7.html) |
| AU (3) | AU2016323017B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3350213T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2879287T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL257840B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2018003062A (cg-RX-API-DMAC7.html) |
| SA (1) | SA518391109B1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG10201913868XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017048593A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4339287A3 (en) | 2015-07-31 | 2024-05-22 | Regents Of The University Of Minnesota | Modified cells and methods of therapy |
| SG11201900654QA (en) * | 2016-08-02 | 2019-02-27 | Us Health | Anti-kras-g12d t cell receptors |
| GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
| EP3602053B1 (en) * | 2017-03-31 | 2023-06-28 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Methods of isolating neoantigen-specific t cell receptor sequences |
| US11807662B2 (en) | 2017-05-16 | 2023-11-07 | The Johns Hopkins University | MANAbodies and methods of using |
| CN111511375A (zh) | 2017-06-30 | 2020-08-07 | 因提玛生物科学公司 | 用于基因治疗的腺相关病毒载体 |
| AU2018335274B2 (en) * | 2017-09-20 | 2025-02-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | HLA class II–restricted T cell receptors against mutated RAS |
| US12227554B2 (en) | 2017-10-05 | 2025-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for selectively expanding cells expressing a TCR with a murine constant region |
| MX2020005765A (es) | 2017-12-04 | 2020-09-25 | Us Health | Receptores de celulas t restringidos a antigeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado. |
| SG11202012653XA (en) * | 2018-06-19 | 2021-01-28 | Biontech Us Inc | Neoantigens and uses thereof |
| AU2019321608B2 (en) | 2018-08-16 | 2024-07-25 | Biontech Us Inc. | T cell receptor constructs and uses thereof |
| WO2020154275A1 (en) * | 2019-01-22 | 2020-07-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hla class ii-restricted t cell receptors against ras with g12r mutation |
| GB2613715B (en) | 2019-02-20 | 2023-12-06 | Fred Hutchinson Cancer Center | Binding proteins specific for RAS neoantigens and uses thereof |
| US20220175899A1 (en) * | 2019-04-11 | 2022-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer |
| CN110172089B (zh) * | 2019-06-11 | 2020-01-07 | 北京鼎成肽源生物技术有限公司 | 一种kras突变多抗原组合、靶向kras突变肿瘤ctl及其应用 |
| CN112110995A (zh) * | 2019-06-19 | 2020-12-22 | 上海交通大学医学院 | 肿瘤新抗原多肽及其用途 |
| EP4016437A4 (en) * | 2019-08-14 | 2022-08-17 | NEC Corporation | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD AND RECORDING MEDIUM |
| CN112759641B (zh) * | 2019-11-01 | 2023-01-20 | 香雪生命科学技术(广东)有限公司 | 一种识别Kras G12V的高亲和力TCR |
| WO2021127184A1 (en) | 2019-12-17 | 2021-06-24 | The Johns Hopkins University | MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING |
| JP2023507432A (ja) | 2019-12-20 | 2023-02-22 | インスティル バイオ (ユーケイ) リミテッド | 腫瘍浸潤リンパ球を単離するためのデバイスおよび方法ならびにそれらの使用 |
| MX2022009825A (es) * | 2020-02-14 | 2022-10-13 | Us Health | Receptores de células t restringidas por hla de la clase i contra ras con mutación g12v. |
| US20230159614A1 (en) * | 2020-02-26 | 2023-05-25 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Hla class ii-restricted t cell receptors against ras with g12v mutation |
| CN111574616B (zh) * | 2020-06-17 | 2021-02-02 | 深圳豪石生物科技有限公司 | 分离的t细胞受体和应用 |
| WO2022015922A1 (en) * | 2020-07-16 | 2022-01-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hla class ii-restricted drb t cell receptors against ras with g12v mutation |
| AU2021351710A1 (en) * | 2020-10-02 | 2023-06-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hla class ii-restricted dq t cell receptors against ras with g13d mutation |
| JP2024507929A (ja) | 2021-02-25 | 2024-02-21 | アラウノス セラピューティクス インコーポレイテッド | 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 |
| WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
| CN114920824B (zh) * | 2022-05-27 | 2023-12-05 | 重庆医科大学 | Tcr或其抗原结合片段及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7301017B2 (en) * | 2002-05-30 | 2007-11-27 | Kolesnick Richard N | Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| HUE038833T2 (hu) * | 2005-08-05 | 2018-11-28 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Antigénspecifikus T-sejtek létrehozása |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| SI2755997T1 (sl) * | 2011-09-15 | 2018-11-30 | The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health | T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage |
| GB201314404D0 (en) * | 2013-08-12 | 2013-09-25 | Immunocore Ltd | T Cell Receptors |
| SG10201913978RA (en) * | 2014-11-26 | 2020-03-30 | The United States Of America As Represented By The Secretary | Anti-mutated kras t cell receptors |
-
2016
- 2016-09-09 SG SG10201913868XA patent/SG10201913868XA/en unknown
- 2016-09-09 WO PCT/US2016/050875 patent/WO2017048593A1/en not_active Ceased
- 2016-09-09 KR KR1020257025325A patent/KR20250117744A/ko active Pending
- 2016-09-09 US US15/758,954 patent/US10556940B2/en active Active
- 2016-09-09 ES ES16770408T patent/ES2879287T3/es active Active
- 2016-09-09 EP EP21162567.8A patent/EP3901169B1/en active Active
- 2016-09-09 IL IL257840A patent/IL257840B2/en unknown
- 2016-09-09 EP EP16770408.9A patent/EP3350213B1/en active Active
- 2016-09-09 JP JP2018513423A patent/JP7185524B2/ja active Active
- 2016-09-09 DK DK16770408.9T patent/DK3350213T3/da active
- 2016-09-09 CN CN201680058891.3A patent/CN108350059B/zh active Active
- 2016-09-09 MX MX2018003062A patent/MX2018003062A/es unknown
- 2016-09-09 AU AU2016323017A patent/AU2016323017B2/en active Active
- 2016-09-09 CN CN202111083392.9A patent/CN115073583A/zh active Pending
- 2016-09-09 KR KR1020187010326A patent/KR102841067B1/ko active Active
-
2018
- 2018-03-13 SA SA518391109A patent/SA518391109B1/ar unknown
-
2020
- 2020-01-10 US US16/739,310 patent/US11667692B2/en active Active
-
2021
- 2021-02-10 AU AU2021200833A patent/AU2021200833B2/en active Active
-
2022
- 2022-07-26 AU AU2022209229A patent/AU2022209229B2/en active Active
- 2022-11-25 JP JP2022188263A patent/JP7461445B2/ja active Active
-
2023
- 2023-05-01 US US18/310,141 patent/US12673981B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022050400A5 (cg-RX-API-DMAC7.html) | ||
| CN112300269B (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| TWI801862B (zh) | 抗tigit的抗體、其製備方法和應用 | |
| Clark et al. | Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. | |
| EP3271387B1 (en) | Trispecific binding molecules for treating hbv infection and associated conditions | |
| Sukhatme et al. | The T cell differentiation antigen Leu-2/T8 is homologous to immunoglobulin and T cell receptor variable regions | |
| JP2021191265A5 (cg-RX-API-DMAC7.html) | ||
| JP6397886B2 (ja) | 治療用ペプチド | |
| JP2021520198A5 (cg-RX-API-DMAC7.html) | ||
| CN106029694A (zh) | 治疗性肽 | |
| Chrétien et al. | CTX, a novel molecule specifically expressed on the surface of cortical thymocytes in Xenopus | |
| KR20210121141A (ko) | Cd3-특이적 결합 분자 | |
| CN103097414B (zh) | 膜联蛋白1抗体 | |
| JP7735285B2 (ja) | G12v突然変異rasに対するhlaクラスi拘束性t細胞受容体 | |
| JP2025063321A5 (cg-RX-API-DMAC7.html) | ||
| US5601822A (en) | γ, δ T cell receptor and methods for detection | |
| WO2021216468A1 (en) | Human tigit specific single domain antibodies and methods of use | |
| JP2018535647A5 (cg-RX-API-DMAC7.html) | ||
| JP2022523696A (ja) | Car細胞上の非天然nkg2d受容体に、結合した異種分子を選択的に送達する改変非天然nkg2dリガンド | |
| Henwood et al. | Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65‐kDa heat‐shock protein: selective in vivo expansion of T cells bearing defined receptors | |
| JPH08501925A (ja) | 糖蛋白pに対するモノクローナル抗体 | |
| Bjorkman et al. | Model for the interaction of T-cell receptors with peptide/MHC complexes | |
| JP2022523024A5 (cg-RX-API-DMAC7.html) | ||
| WO2019192493A1 (zh) | 抗人lag-3单克隆抗体及其应用 | |
| Polakova et al. | Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity |